UK investigates weight-loss jab risks after many hospitalised with pancreatitis

Hi
By -
0
The UK’s MHRA and Genomics England have launched a groundbreaking study to investigate whether genetics play a role in developing acute pancreatitis after taking GLP-1 weight-loss drugs like Ozempic, Mounjaro, and Wegovy.

from mint - news https://ift.tt/AxLfpur
via IFTTT

Post a Comment

0Comments

Post a Comment (0)